The gut microbiota and immune checkpoint inhibitors

por Humphries, Audrey, Daud, Adil
Publicado 2018

Nivolumab plus ipilimumab in the treatment of advanced melanoma

por Tsai, Katy K., Daud, Adil I.
Publicado 2015

Intratumoral therapies and in-situ vaccination for melanoma

por Huppert, Laura A., Daud, Adil I.
Publicado 2022

Treatment of cutaneous melanoma: current approaches and future prospects

por Algazi, Alain P, Soon, Christopher W, Daud, Adil I
Publicado 2010

Indirect treatment comparison of dabrafenib plus trametinib versus vemurafenib plus cobimetinib in previously untreated metastatic melanoma patients

por Daud, Adil, Gill, Japinder, Kamra, Sheily, Chen, Lei, Ahuja, Amit
Publicado 2017

Long-term overall survival from a phase I trial using intratumoral plasmid interleukin-12 with electroporation in patients with melanoma

por Daud, Adil, Takamura, Kathryn Toshimi, Diep, Tu, Heller, Richard, Pierce, Robert H
Publicado 2015

Combined dabrafenib and trametinib therapy in metastatic melanoma and organ transplantation: Case report and review of the literature

por Garrett, Giorgia L., He, Steven Y., Sabouni, Nica, Daud, Adil, Arron, Sarah T.
Publicado 2015

In-field and abscopal response after short-course radiation therapy in patients with metastatic Merkel cell carcinoma progressing on PD-1 checkpoint blockade: a case series

por Xu, Melody J., Wu, Susan, Daud, Adil I., Yu, Siegrid S., Yom, Sue S.
Publicado 2018

Cytokines, Chemokines, and Other Biomarkers of Response for Checkpoint Inhibitor Therapy in Skin Cancer

por Bridge, Jennifer A., Lee, James C., Daud, Adil, Wells, James W., Bluestone, Jeffrey A.
Publicado 2018

The Liver–Immunity Nexus and Cancer Immunotherapy

por Lee, James C., Green, Michael D., Huppert, Laura A., Chow, Christine, Pierce, Robert H., Daud, Adil I.
Publicado 2022

Pulsed Electric Fields in Oncology: A Snapshot of Current Clinical Practices and Research Directions from the 4th World Congress of Electroporation

por Campana, Luca G., Daud, Adil, Lancellotti, Francesco, Arroyo, Julio P., Davalos, Rafael V., Di Prata, Claudia, Gehl, Julie
Publicado 2023

Intratumoral electroporation of plasmid interleukin-12: efficacy and biomarker analyses from a phase 2 study in melanoma (OMS-I100)

por Daud, Adil, Algazi, Alain, Ashworth, Michelle, Buljan, Michael, Takamura, Kathryn Toshimi, Diep, Tu, Pierce, Robert H, Bhatia, Shailender
Publicado 2015

Tissue-specific Tregs in cancer metastasis: opportunities for precision immunotherapy

por Huppert, Laura A., Green, Michael D., Kim, Luke, Chow, Christine, Leyfman, Yan, Daud, Adil I., Lee, James C.
Publicado 2021

Increased FDG avidity in lymphoid tissue associated with response to combined immune checkpoint blockade

por Tsai, Katy K., Pampaloni, Miguel H., Hope, Charity, Algazi, Alain P., Ljung, Britt-Marie, Pincus, Laura, Daud, Adil I.
Publicado 2016

Phase II randomised discontinuation trial of the MET/VEGF receptor inhibitor cabozantinib in metastatic melanoma

por Daud, Adil, Kluger, Harriet M, Kurzrock, Razelle, Schimmoller, Frauke, Weitzman, Aaron L, Samuel, Thomas A, Moussa, Ali H, Gordon, Michael S, Shapiro, Geoffrey I
Publicado 2017

Should Sentinel Lymph Node Biopsy Status Guide Adjuvant Radiation Therapy in Patients With Merkel Cell Carcinoma?

por Ahmad, Tessnim R., Vasudevan, Harish N., Lazar, Ann A., Chan, Jason W., George, Jonathan R., Alvarado, Michael D., Yu, Siegrid S., Daud, Adil, Yom, Sue S.
Publicado 2021

Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy

por Nosrati, Adi, Tsai, Katy K, Goldinger, Simone M, Tumeh, Paul, Grimes, Barbara, Loo, Kimberly, Algazi, Alain P, Nguyen-Kim, Thi Dan Linh, Levesque, Mitchell, Dummer, Reinhard, Hamid, Omid, Daud, Adil
Publicado 2017

Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006

por Hamid, Omid, Robert, Caroline, Ribas, Antoni, Hodi, F. Stephen, Walpole, Euan, Daud, Adil, Arance, Ana S., Brown, Ewan, Hoeller, Christoph, Mortier, Laurent, Schachter, Jacob, Long, Jianmin, Ebbinghaus, Scot, Ibrahim, Nageatte, Butler, Marcus
Publicado 2018

Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer

por Terranova-Barberio, Manuela, Pawlowska, Nela, Dhawan, Mallika, Moasser, Mark, Chien, Amy J., Melisko, Michelle E., Rugo, Hope, Rahimi, Roshun, Deal, Travis, Daud, Adil, Rosenblum, Michael D., Thomas, Scott, Munster, Pamela N.
Publicado 2020

The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis

por Riker, Adam I, Enkemann, Steven A, Fodstad, Oystein, Liu, Suhu, Ren, Suping, Morris, Christopher, Xi, Yaguang, Howell, Paul, Metge, Brandon, Samant, Rajeev S, Shevde, Lalita A, Li, Wenbin, Eschrich, Steven, Daud, Adil, Ju, Jingfang, Matta, Jaime
Publicado 2008